Lobectomy News and Research

RSS

GGO-dominant lung tumors have excellent prognosis

Ground glass opacity-dominant clinical stage IA lung adenocarcinoma is a low-grade malignancy with an “excellent” prognosis, Japanese researchers believe.

10 Sep 2013

Specific pattern in lung tumor pathology is strong predictor of recurrence, says study

A new study by thoracic surgeons and pathologists at Memorial Sloan-Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence.

8 Aug 2013

New minimally invasive surgery for epilepsy offers quicker recuperation time for patients

A new minimally invasive laser-based tool for epilepsy surgery offers a quicker recuperation time for patients than major surgery, Mayo Clinic researchers report. The research is ongoing, but preliminary results were recently presented at the American Academy of Neurology.

6 Jun 2013

Study reports liver donors face mortality risk with LDLT

A study published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, reports that donor mortality is about 1 in 500 donors with living donor liver transplantation (LDLT).

26 Apr 2013

Obesity ramps up thoracic surgery costs

Obese patients have significantly increased operating times when undergoing lobectomy for primary lung cancer, show US study results.

5 Dec 2012

Lobectomy for primary lung cancer takes longer in obese patients

Lobectomy for primary lung cancer takes longer when a patient is obese, not only increasing the resources required to achieve a good outcome, but also adding to national health care costs, according to a study published in the December 2012 issue of The Annals of Thoracic Surgery.

29 Nov 2012

Breath testing could discriminate between benign and malignant pulmonary nodules

A pilot study, published in the October 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed that breath testing could be used to discriminate between benign and malignant pulmonary nodules.

17 Sep 2012

Lymph node dissection may not be necessary for localized non-small cell lung cancers

Lymph node dissection, the current standard surgical treatment for localized non-small cell lung cancers, may be unnecessary in certain screen-detected early stage cases , according to a study published in the March issue of the Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer.

1 Mar 2011

Study discovers health care gap in treating young patients with thyroid cancer

Thyroid cancer is the third most common malignancy in children, and the incidence is rising approximately one percent per year. Now a new analysis published in the October issue of Annals of Surgical Oncology indicates that although the proportion of young patients undergoing total thyroidectomy increased by 34 percent between 1985 and 2007, a variety of hospital and patient factors—including disparities in access to surgeons and state-of-the-art care—affect whether a child actually receives this procedure or another less extensive operation.

16 Nov 2010

IsoRay initiates study of Cesium-131 brachytherapy seeds for NSCLC cancer

IsoRay, Inc. announced today the initiation of a multi-institutional study of Cesium-131 brachytherapy seeds (internal radiation therapy) for use in Non Small Cell Lung Cancers (NSCLC). A number of institutions and physicians will be working to collect scientific data to further the use of Cesium-131 internal radiation therapy in conjunction with surgery for NSCLC.

14 Oct 2010

Cs-131 brachytherapy seed implant can treat metastasized cancer

IsoRay, Inc. announced today another milestone in the use of Cesium-131 (Cs-131) brachytherapy seeds (internal radiation therapy). Doctors at a world renowned medical facility have performed the world's first Cs-131 brachytherapy seed implant following a wedge resection of a lung tumor which originated from a form of malignant uterine cancer. Initially used to treat primary cancers, Cs-131 seeds are now being used to treat metastasized cancer.

7 Oct 2010

BioDigital, NYU Langone partner to create Right Upper Lobe Resection Cognitive Task Trainer

SensAble Technologies, a leader in haptic devices and 3D modeling solutions, announced that its customer, BioDigital, working in partnership with surgeons at NYU Langone Medical Center, has created the first medical simulation application for teaching residents the high-technology procedure for lung resection of the right upper lobe, most commonly performed to treat resectable lung cancers.

23 Jun 2010

Patients with stage IIIA NSCLC who receive lobectomy have increased overall survival: Research

There's debate about the best treatment approach for patients with certain stages of non-small cell lung cancer, which accounts for about 80 percent of all lung cancers. Patients with early stages of NSCLC are typically treated with surgery, but those with stage IIIA present more of a challenge because they are such a diverse group.

29 May 2010

Study reveals less invasive procedure beneficial for patients with sufficient lung function

Research published in the April edition of the Journal of Thoracic Oncology sought to compare the outcomes of a sleeve lobectomy and a pneumonectomy procedure, in order to determine which is a more acceptable standard treatment for patients with non-small cell lung cancer.

2 Apr 2010

Hepatectomy effective for treatment of caudate lobe HCC

Caudate hepatocellular carcinoma (HCC) has a poorer prognosis than HCC originating from other lobes, due to its proximity to the portal trunk and inferior vena cava, which facilitate intrahepatic and systemic spread early in the disease. Hepatic resection is considered, in principle, to be the first choice treatment. In order to improve surgical outcome, it is necessary to evaluate the potential risk factors affecting long-term survival and to establish guidelines for the appropriate use of hepatectomy for caudate lobectomy.

31 Mar 2010

Role of surgery and subsequent need for RT in treatment of stage I SCLC

Research published in February's edition of the Journal of Thoracic Oncology investigates the utilization of surgery and the subsequent need for radiotherapy (RT) when treating stage I small cell lung cancer (SCLC). Traditionally, SCLC treatment regimes include chemotherapy and radiotherapy for limited stage disease; however, the study concludes that in selected patients with early stage disease a lobectomy (removal of lung) had an excellent overall survival without additional treatment.

17 Feb 2010

New minimally invasive surgery for lung cancer reduces post-operative pain

Generally, after traditional open-chest surgery for lung cancer, patients may experience a significant amount of pain and spend up to a week in the hospital followed by months recovering.

20 Jan 2010

Correcting birth defects

Traditionally when a baby was born with a malformation of the lung or esophagus, they had to undergo open surgery involving a large chest incision with risk for serious complications.

18 Jul 2007

Thoracoscopic lobectomy can improve chemotherapy for lung cancer outcomes

Patients who undergo a minimally invasive lung cancer surgery called thoracoscopic lobectomy may derive more benefit from the chemotherapy that follows, according to Duke University Medical Center researchers.

10 Apr 2007

Minimally invasive lung surgery has low risk with same results as open surgery

In the largest published study of its kind, with 1,100 patient cases reviewed, a minimally invasive surgical procedure for lung cancer has been shown to be as effective as open surgery with a low risk of complications and high survival rates when performed by experienced thoracic surgeons.

7 Feb 2006